NCT04687826

Brief Summary

Postoperative complication rates in patients undergoing pancreaticoduodenectomy remain high although the operation techniques have developed a lot in recent years. There is evidence that restrictive intraoperative fluid therapy could decrease postoperative complication rates but the results of the former studies have been somewhat controversial. The aim of this study is to examine whether the intraoperative and postoperative fluid therapy affect to the postoperative complication rates in patients undergoing pancreaticoduodenectomy.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
168

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2015

Longer than P75 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2015

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2017

Completed
2.9 years until next milestone

Study Completion

Last participant's last visit for all outcomes

November 20, 2020

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

December 20, 2020

Completed
9 days until next milestone

First Posted

Study publicly available on registry

December 29, 2020

Completed
Last Updated

December 29, 2020

Status Verified

December 1, 2020

Enrollment Period

3 years

First QC Date

December 20, 2020

Last Update Submit

December 28, 2020

Conditions

Keywords

pancreaticoduodenectomyClavien-Dindo classificationpancreatic fistulas

Outcome Measures

Primary Outcomes (2)

  • Intraoperative fluid volume

    The amount of fluid (crystalloids and albumin) patients got during the surgery

    The duration of the surgery

  • Postoperative complications (Clavien-Dindo classification)

    The rate of severe Clavien-Dindo complications (3-5)

    Postoperative day 0-30

Secondary Outcomes (6)

  • Severe surgical complications

    Postoperative day 0-30

  • Cardiopulmonary complications

    Postoperative day 0-30

  • Pancreatic fistulas

    Postoperative day 0-30

  • Postoperative fluid volume

    Postoperative day 0-3

  • Intraoperative fluid balance

    The duration of the surgery

  • +1 more secondary outcomes

Study Arms (2)

Pancreaticoduodenectomy in 2015

Patients who underwent pancreaticoduodenectomy in 2015 got intraoperative fluid therapy in goal directed fluid therapy technique. Most of the patients spent the first postoperative night in ICU where the monitoring of urine output and fluid balance are more specific than in a normal ward.

Other: Goal directed fluid therapy

Pancreaticoduodenectomy in 2017

Patients who underwent pancreaticoduodenectomy in 2017 got liberal intraoperative fluid therapy and most of the patients spent the first postoperative night in a regular ward.

Other: Liberal fluid therapy

Interventions

Patients in 2015 got intraoperative fluid therapy in goal directed fluid therapy technique.

Pancreaticoduodenectomy in 2015

Patients in 2017 got liberal intraoperative fluid therapy influenced by their anaesthesiologist.

Pancreaticoduodenectomy in 2017

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

All patients who have underwent pancreaticoduodenectomy in years 2015 and 2017 are counted in the study.

You may qualify if:

  • age 18 or over
  • patients who underwent pancreaticoduodenectomy in 2015 or in 2017

You may not qualify if:

  • patients whose patient record information is insufficient

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Postoperative ComplicationsPancreatic Fistula

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and SymptomsDigestive System FistulaDigestive System DiseasesPancreatic DiseasesFistulaPathological Conditions, Anatomical

Study Officials

  • Piia Peltoniemi, M.D.

    Helsinki University Central Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
M.D. Principal Investigator

Study Record Dates

First Submitted

December 20, 2020

First Posted

December 29, 2020

Study Start

January 1, 2015

Primary Completion

December 31, 2017

Study Completion

November 20, 2020

Last Updated

December 29, 2020

Record last verified: 2020-12

Data Sharing

IPD Sharing
Will not share